Clinical trials
Completed Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,447 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 29 |
| 2001 | 33 |
| 2002 | 34 |
| 2003 | 44 |
| 2004 | 46 |
| 2005 | 54 |
| 2006 | 60 |
| 2007 | 68 |
| 2008 | 63 |
| 2009 | 58 |
| 2010 | 64 |
| 2011 | 64 |
| 2012 | 50 |
| 2013 | 58 |
| 2014 | 62 |
| 2015 | 72 |
| 2016 | 66 |
| 2017 | 81 |
| 2018 | 78 |
| 2019 | 54 |
| 2020 | 49 |
| 2021 | 49 |
| 2022 | 32 |
| 2023 | 29 |
| 2024 | 15 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,447 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 74 |
| Memorial Sloan Kettering Cancer Center | 60 |
| Gynecologic Oncology Group | 44 |
| AstraZeneca | 36 |
| M.D. Anderson Cancer Center | 26 |
| Dana-Farber Cancer Institute | 18 |
| ARCAGY/ GINECO GROUP | 17 |
| Eli Lilly and Company | 17 |
| Hoffmann-La Roche | 16 |
| AGO Study Group | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 1,447 |
| Fallopian Tube Neoplasms | 335 |
| Breast Neoplasms | 287 |
| Carcinoma, Ovarian Epithelial | 250 |
| Neoplasms | 147 |
| Endometrial Neoplasms | 136 |
| Uterine Cervical Neoplasms | 127 |
| Colorectal Neoplasms | 124 |
| Carcinoma, Non-Small-Cell Lung | 121 |
| Lung Neoplasms | 115 |
Trials
Showing 76 to 100 of 1,447. Each trial links to its page on Pharma Observatory.
1,347 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.